VPT — VentriPoint Diagnostics Income Statement
0.000.00%
Last trade - 00:00
- CA$36.15m
- CA$34.28m
- CA$0.07m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.06 | 0.081 | 0.036 | 0 | 0.068 |
Cost of Revenue | |||||
Gross Profit | 0.026 | 0.037 | 0.026 | -0.006 | 0.058 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3.88 | 3.4 | 1.91 | 3.8 | 4.98 |
Operating Profit | -3.82 | -3.32 | -1.87 | -3.8 | -4.91 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.08 | -3.32 | -1.85 | -3.88 | -4.87 |
Net Income After Taxes | -2.08 | -3.32 | -1.85 | -3.88 | -4.87 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.08 | -3.32 | -1.85 | -3.88 | -4.87 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.08 | -3.32 | -1.85 | -3.88 | -4.87 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.037 | -0.052 | -0.025 | -0.028 | -0.031 |